Lower Urinary Tract Symptoms: What’s New in Medical Treatment?
Author:
Publisher
Elsevier BV
Subject
Urology
Reference39 articles.
1. α-Blockers, 5-α-reductase inhibitors, acetylcholine, β3 agonists, and phosphodiesterase-5s in medical management of lower urinary tract symptoms/benign prostatic hyperplasia: how much do the different formulations actually matter in the classes?;Chughtai;Urol Clin North Am,2016
2. Safety and tolerability of the β3-adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised phase III trials and of a 1-year randomised phase III trial;Nitti;Int J Clin Pract,2014
3. Gibson W, MacDiarmid S, Huang M, et al. Treating overactive bladder in older patients with a combination of mirabegron and solifenacin: a prespecified analysis from the BESIDE study. Eur Urol Focus [In press]. https://doi.org/10.1016/j.euf.2017.08.008.
4. A randomized controlled study of the efficacy of tamsulosin monotherapy and its combination with mirabegron for overactive bladder induced by benign prostatic obstruction;Ichihara;J Urol,2015
5. Safety and tolerability of β3-adrenoceptor agonists in the treatment of overactive bladder syndrome—insight from transcriptosome and experimental studies;Michel;Expert Opin Drug Saf,2016
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Interrelations between factors in the development of inflammatory changes in the urinary tract in the comprehensive treatment of patients with urolithiasis;Zaporozhye Medical Journal;2024-07-17
2. Correction of nocturia in patients with benign prostatic hyperplasia. Mini-review and analysis of clinical observations;Consilium Medicum;2024-05-02
3. Nocturia;Urologie pro praxi;2024-03-15
4. Efficacy and safety of desmopressin in nocturia and nocturnal polyuria control of neurological patients: A systematic review and meta‐analysis;Neurourology and Urodynamics;2023-09-25
5. Palladium-Catalyzed Oxidative Cycloaddition of Quinazoline-2,4(1H,3H)-diones and Diarylalkynes via C–H/N–H Activation;Synthesis;2023-06-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3